-Search query
-Search result
Showing 1 - 50 of 1,434 items for (author: andrew & b & ward)
EMDB-41374:
Antibody N3-1 bound to RBDs in the up and down conformations
Method: single particle / : Hsieh CL, McLellan JS
EMDB-41382:
Antibody N3-1 bound to RBD in the up conformation
Method: single particle / : Hsieh CL, McLellan JS
EMDB-41399:
Antibody N3-1 bound to SARS-CoV-2 spike
Method: single particle / : Hsieh CL, McLellan JS
PDB-8tm1:
Antibody N3-1 bound to RBDs in the up and down conformations
Method: single particle / : Hsieh CL, McLellan JS
PDB-8tma:
Antibody N3-1 bound to RBD in the up conformation
Method: single particle / : Hsieh CL, McLellan JS
EMDB-41043:
Structure of mechanically activated ion channel OSCA1.2 in peptidiscs
Method: single particle / : Burendei B, Jojoa-Cruz S, Lee WH, Ward AB
EMDB-41044:
Structure of mechanically activated ion channel OSCA2.3 in peptidiscs
Method: single particle / : Jojoa-Cruz S, Burendei B, Lee WH, Ward AB
PDB-8t56:
Structure of mechanically activated ion channel OSCA1.2 in peptidiscs
Method: single particle / : Burendei B, Jojoa-Cruz S, Lee WH, Ward AB
PDB-8t57:
Structure of mechanically activated ion channel OSCA2.3 in peptidiscs
Method: single particle / : Jojoa-Cruz S, Burendei B, Lee WH, Ward AB
EMDB-40242:
BG505 MD39 SOSIP in complex with Rh.NJ85 wk12 gp120GH, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40243:
BG505 MD39 SOSIP in complex with Rh.NJ86 wk12 V1V3, C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40244:
BG505 MD39 SOSIP in complex with Rh.NJ76 wk12 C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40252:
BG505 MD39 SOSIP in complex with Rh.NK04 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40254:
BG505 MD39 SOSIP in complex with Rh.NJ75 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40255:
BG505 MD39 SOSIP in complex with Rh.NJ87 wk12 C3V5 and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40256:
BG505 MD39 SOSIP in complex with Rh.NJ84 wk12 V1V3, gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40257:
BG505 MD39 SOSIP in complex with Rh.NJ77 wk12 V1V3, C3V5, N611/FP and base epitope polyclonal
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-28850:
SARS-CoV-2 Gamma 6P Mut7 S + COVA309-3 Fab
Method: single particle / : Torres JL, Ward AB
EMDB-28851:
SARS-CoV-2 Gamma 6P Mut7 S + COVA309-10 Fab
Method: single particle / : Torres JL, Ward AB
EMDB-28852:
SARS-CoV-2 Omicron 6P S + COVA309-35 Fab
Method: single particle / : Torres JL, Ward AB
EMDB-28853:
SARS-CoV-2 Gamma 6P Mut7 + S COVA309-38 Fab
Method: single particle / : Torres JL, Ward AB
EMDB-40088:
HIV-1 Env subtype C CZA97.12 SOSIP.664 in complex with 3BNC117 Fab
Method: single particle / : Ozorowski G, Lee JH, Ward AB
PDB-8gje:
HIV-1 Env subtype C CZA97.12 SOSIP.664 in complex with 3BNC117 Fab
Method: single particle / : Ozorowski G, Lee JH, Ward AB
EMDB-41464:
H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting 1-1-1F05
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41465:
H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1F05
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41466:
H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 1-1-1E04
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41467:
H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1E04
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41468:
H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 4-1-1E02
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41469:
H2 hemagglutinin (A/Singapore/1/1957) in complex with Sa-targeting Fab 4-1-1G03
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41470:
H2 hemagglutinin (A/Singapore/1/1957) in complex with medial-junction-targeting Fab 2-2-1G06
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41471:
H1 hemagglutinin (NC99) in complex with medial-junction-targeting Fab 2-2-1G06
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41472:
H2 hemagglutinin (A/Singapore/1/1957) in complex with polyclonal Fab, pAb_1
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41473:
H2 hemagglutinin (A/Singapore/1/1957) in complex with polyclonal Fab, pAb_2
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41474:
H2 hemagglutinin (A/Singapore/1/1957) in complex with polyclonal Fab, pAb_3
Method: single particle / : Yang YR, Han J, Perrett HR, Ward AB
EMDB-41523:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41524:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41525:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41526:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41527:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-2 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41528:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-2 week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41529:
Polyclonal immune complex of Fab binding to H2 HA from serum of subject 2-2 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41530:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-3 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41531:
Polyclonal immune complex of Fab binding H2 HA from serum of subject 2-3 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41560:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41561:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 2-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41562:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 2-2 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41563:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 2-2 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41564:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 2-2 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41683:
H2 HA in complex with Cb-targeting mAb 2-2-1E08
Method: single particle / : Yang YR, Han J, Ward AB
EMDB-41684:
H2 HA in complex with esterase-targeting mAb 2-2-1C06
Method: single particle / : Yang YR, Han J, Ward AB
Pages: